awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36402230-D91B21CE-B179-4EB1-AA00-3F00490BF0E0
Q36402230-D91B21CE-B179-4EB1-AA00-3F00490BF0E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36402230-D91B21CE-B179-4EB1-AA00-3F00490BF0E0
Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.
P2860
Q36402230-D91B21CE-B179-4EB1-AA00-3F00490BF0E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36402230-D91B21CE-B179-4EB1-AA00-3F00490BF0E0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cedffb91b9185c826b0e617791b846b6e8bcf22b
P2860
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.